geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Cost of stress urinary incontinence: a claims data analysis


, : Cost of stress urinary incontinence: a claims data analysis. Pharmacoeconomics 22(2): 95-105

The primary objectives of this research were to: (i) identify and present methodologies for estimating three types of 'cost-of-illness' measures using healthcare and disability claims data -- specifically 'cost of treatment', 'incremental cost of patient', and 'incremental cost of illness'; and (ii) perform a case-study analysis of these cost measures for women treated for stress urinary incontinence (SUI). In this paper, we discuss aspects of cost-of-illness methodologies in the context of SUI. We first distinguish between 'cost of treatment' (i.e. the costs of treating a specific condition), 'incremental cost of patient' (i.e. the additional costs associated with patients with a particular condition, irrespective of any comorbid conditions they may also have), and 'incremental cost of illness' (i.e. the additional costs resulting from a particular illness, as distinct from the costs of other conditions that the patient might have, including conditions which might have caused the illness in question). The latter case is in many ways the most complex to model, requiring controls for related causal conditions. We then applied these three methodologies by analysing the costs associated with SUI. Using data from a large employer claims database (n > 100 000), we estimated a series of regression models that reflected cost of treatment, incremental cost of patient, and incremental cost of illness for SUI. The three approaches yielded substantially different results. For many purposes the incremental cost-of-illness model provides the most appropriate results, as it controls for comorbid conditions, as well as patient demographics. On a per capita basis using the incremental cost-of-illness model, patients with SUI had direct costs that were 134% more than those for their controls and indirect costs that were 163% more than those for controls. Estimating costs for the average (i.e. mean) person results in dollar-termed estimates of the costs of SUI. In particular, we found that in 1998, the average direct medical cost of SUI was $US5642 and the indirect workplace cost of SUI was $US4208. Since the various methods yield substantially different results, it is important that the end user of cost-of-illness analyses of claims data have a clear purpose in mind when reporting the cost of the condition of concern. The incremental cost-of-illness measure for claims data has substantial advantages in terms of enhancing our understanding of the specific cost impact of SUI.

US$29.90

PMID: 14731051


Other references

Anonymous, 1968: Progress in reproductive endocrinology. California Medicine 109(6): 518-519

Nebbia, P.; Tramuta, C.; Odore, R.; Nucera, D.; Zanatta, R.; Robino, P., 2015: Genetic and phenotypic characterisation of Escherichia coli producing cefotaximase-type extended-spectrum β-lactamases: first evidence of the ST131 clone in cats with urinary infections in Italy. The incidence of cefotaximase (CTX-M)-type extended-spectrum β-lactamase (ESBL)-producing Escherichia coli has increased dramatically in humans and animals since the middle of the last century. E coli that produce CTX-M β-lactamase represent a m...

Singh, A.; Gopinath, K.; Sharma, P.; Bisht, D.; Sharma, P.; Singh, N.; Singh, S., 2016: Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant. Tuberculosis is a major health problem in India, and the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains of Mycobacterium tuberculosis (Mtb) has further complicated the situation. Though several studies characte...

Hart, S.P.; Smith, J.R.; Dransfield, I., 2004: Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement. Efficient phagocytic clearance of apoptotic cells is crucial in many biological processes. A bewildering array of phagocyte receptors have been implicated in apoptotic cell clearance, but there is little convincing evidence that they act directly...

Irish, John, 1992: Rectification of misleading locality data recently published for Namibian Tabanidae. Cimbebasia 13(0): 183, 1991

Smirina E.M., 1980: Growth rate and survival of common frogs rana temporaria during the 1st years of life. The population density of young-of-the-year exerted no influence on survival, while marking by the amputation of digit phalanxes decreased survival. The main death of young-of-the-year was observed during the first weeks after metamorphosis. The f...

Shu Xianhong, Et@al, 1996: Ultrasound disruption of atherosclerotic plaque in vitro study. The purposes of this study were to measure the relation between ultrasonic disruption and thermal damage of arterial wall and to measure the size of debris particles of disruption. Five human atherosclerotic arteries were studied in vitro. Both 25...

Diaz, D.; Lick, D.; Abdel-Aty, K.; Dulku, J.; Mir, K.; Ricketts, R., 2016: Comparison of Exclusion Rates Between Station-based and Single Provider Preparticipation Evaluations: 340 Board #177 June 1, 11: 00 AM - 12: 30 PM. Medicine and Science in Sports and Exercise 48(5 Suppl 1): 88-88

Zafar, M.S.; Mellinger, R.C.; Chason, J.L., 1984: Cushing's disease due to pituitary carcinoma. Henry Ford Hospital Medical Journal 32(1): 61-66

de Rezende, Márcia.Uchoa.; Rosa, T.Bittencourt.Carvalho.; Pasqualin, T.; Frucchi, R.; Okazaki, E.; Villaça, P.Ribeiro., 2015: Subjective results of joint lavage and viscosupplementation in hemophilic arthropathy. To assess whether joint lavage, viscosupplementation and triamcinolone improve joint pain, function and quality of life in patients with severe hemophilic arthropathy. Fourteen patients with knee and/or ankle hemophilic arthritis with and without...